Galapagos achieves milestone in osteoporosis collaboration with Lilly
Advertisement
Galapagos NV announced that it has reached a milestone in its osteoporosis collaboration with Eli Lilly and Company, triggering a payment of €2.5 million from Lilly.
In December 2007, Lilly and Galapagos initiated an alliance to develop new medicines for the treatment of osteoporosis. The agreement provides Lilly access to 12 of Galapagos' novel target based programs in osteoporosis, with Galapagos responsible for the development of drug candidates through to Phase IIa clinical Proof of Concept. The milestone is the result of one of these programs reaching the next phase of medicinal chemistry optimization. To date, Galapagos has received a total of €3.9 million in milestone payments from Lilly under the alliance.
Most read news
Organizations
Other news from the department research and development

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Genmab announces progress with Lundbeck collaboration - First pre-clinical milestone met in Lundbeck collaboration
Olympus Sponsors Free Access to Nature Publishing Group Papers Covering Significant Advances in Neurotechniques

Structure of tuberculosis drug target determined
Thermo Fisher Scientific Announces Collaboration to Establish New Tokyo Biomarker Research Center

Using tattoo ink to find cancer - How commonly used coloring agents could help improve cancer detection
Study finds interferon, one of the body's proteins, induces persistent viral infection - The findings suggest a new approach to clearing infections from AIDS to hepatitis
Mental Fitness Improved by Multilingualism?
